English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduWhen Paxlovid became available for wider use earlier this year, multiple reports of COVID rebound in patients who had taken the antiviral treatment soon followed, leading some doctors to reconsider prescribing it for lower-risk patients. However, a new study has…
Tag: COVID Treatment
High Blood Viscosity Can Predict Higher Risk of Death in Hospitalized COVID-19 Patients
EMBARGOED UNTIL JULY 18, 2022, 2PM EST Study Title: “Association of Blood Viscosity with Mortality among Patients Hospitalized with COVID-19” Journal: Journal of the American College of Cardiology – *Embargoed until July…
New Oral Antiviral Drug Reduces Death in Early COVID-19
Researchers note that health care providers are now able to add to their armamentarium against COVID-19 their prescription of this new antiviral drug for high-risk, newly-infected patients as soon as possible following diagnosis or within five days of the onset of symptoms.
Treating newly infected COVID-19 patients with plasma from COVID survivors demonstrates no significant benefit, study finds
A NIH study co-led and designed by Michigan Medicine researchers found that using convalescent plasma to treat newly infected #COVID-19 patients demonstrated no significant benefit. The trial was stopped in February 2021 due to lack of efficacy based on planned interim analysis
Treating newly infected COVID-19 patients with plasma from COVID survivors demonstrates no significant benefit, study finds
A NIH study co-led and designed by Michigan Medicine researchers found that using convalescent plasma to treat newly infected #COVID-19 patients demonstrated no significant benefit. The trial was stopped in February 2021 due to lack of efficacy based on planned interim analysis
New protein engineering method could accelerate the discovery of COVID-19 therapeutics
Discovering and engineering nanobodies with properties suitable for treating human diseases ranging from cancer to COVID-19 is a time-consuming, laborious process.
University of Miami Miller School of Medicine Leads Groundbreaking Trial for COVID -19 Treatment
University of Miami Miller School of Medicine researchers led a unique and groundbreaking randomized controlled trial showing umbilical cord derived mesenchymal stem cell infusions safely reduce risk of death and quicken time to recovery for the severest COVID-19 patients, according to results published in STEM CELLS Translational Medicine in January 2021.
UNLV Immunologist on the Differences Between Two Leading COVID-19 Vaccine Candidates
Millions around the world have waited for news about a COVID-19 vaccine, regarding it as the beginning of the end for the global pandemic and a herald for the eventual return to “normal life.” Recent announcements from pharmaceutical companies Pfizer and Moderna that their respective late-stage vaccine trials have shown a 90% or better effectiveness rate have received international applause, excitement furthered with estimates that doses could be ready as early as December.
Could the time of day impact the effectiveness of COVID-19 treatment?
For months, experts have warned against the use of anti-inflammatory medications, such as ibuprofen, to treat COVID-19 symptoms. But could the timing of when this drug is taken play a role in its effectiveness?
Mount Sinai Health System, Emergent BioSolutions, and ImmunoTek Bio Centers Form Collaboration to Develop Emergent’s COVID-19 Hyperimmune Globulin (COVID-HIG) Product Candidate with U.S. Department of Defense Funding
Mount Sinai and Emergent to conduct clinical trials to evaluate COVID-HIG for post-exposure prophylaxis of COVID-19 in front-line health care workers and to support a potential Expanded Access Program for military personnel with funding from the U.S. Department of Defense
– ImmunoTek to extend operating license and provide training to Mount Sinai to establish onsite plasma collection to support production of COVID-HIG
Expert available to speak about legal response to fraudulent COVID-19 cures and treatments
By: Mark Blackwell Thomas | Published: May 14, 2020 | 12:36 pm | SHARE: As the number of COVID-19 cases in the U.S. continues to increase, one Florida State University researcher said the number of people looking to profit from the misfortune by offering false, unproven cures is also on the rise. There is no known cure for COVID-19 but Chad Marzen, associate professor of law in the FSU College of Business, said that hasn’t stopped opportunists from looking to capitalize off people’s fears.
Blood Thinners may Improve Survival among Hospitalized COVID-19 Patients
Research could change standard of care protocols to prevent clotting associated with coronavirus